Book chapters
| Hermann A, Tarakdjian GN, Temp AGM, Kasper E, Machts J, Kaufmann J, Vielhaber S, Prudlo J, Cole JH, Teipel S, Dyrba M. Cognitive and behavioural but not motor impairment increases brain age in amyotrophic lateral sclerosis. Brain Commun. 2022, 4(5):fcac239. doi: 10.1093/braincomms/fcac239. eCollection 2022. |
| Temp AGM, Kasper E, Machts J, Vielhaber S, Teipel S, Hermann A, Prudlo J. Cognitive reserve protects ALS-typical cognitive domains: A longitudinal study. Ann Clin Transl Neurol. 2022, 9(8):1212-1223. doi: 10.1002/acn3.51623. Epub 2022 Jul 22. |
| Nelke C, Schroeter CB, Stascheit F, Pawlitzki M, Regner-Nelke L, Huntemann N, Arat E, Öztürk M, Melzer N, Mergenthaler P, Gassa A, Stetefeld H, Schroeter M, Berger B, Totzeck A, Hagenacker T, Schreiber S, Vielhaber S, Hartung HP, Meisel A, Wiendl H, Meuth SG, Ruck T. Eculizumab versus rituximab in generalised myasthenia gravis. J Neurol Neurosurg Psychiatry. 2022, 93(5):548-554. doi: 10.1136/jnnp-2021-328665. Epub 2022 Mar |
| Wigand B, Schlichte I, Schreiber S, Heitmann J, Meyer T, Dengler R, Petri S, Haghikia A, Vielhaber S, Vogt S. Characteristics of pain and the burden it causes in patients with amyotrophic lateral sclerosis - a longitudinal study. Amyotroph Lateral Scler Frontotemporal Degener. 2022, 23(3-4):284-291. doi: 10.1080/21678421.2021.1962354. Epub 2021 Aug 14. |
|
Enax-Krumova EK, Dahlhaus I, Görlach J, Claeys KG, Montagnese F, Schneider L, Sturm D, Fangerau T, Schlierbach H, Roth A, Wanschitz JV, Löscher WN, Güttsches AK, Vielhaber S, Hasseli R, Zunk L, Krämer HH, Hahn A, Schoser B, Rosenbohm A, Schänzer A. Small fiber involvement is independent from clinical pain in late-onset Pompe disease. Orphanet J Rare Dis. 2022, 17(1):177. doi: 10.1186/s13023-022-02327-4. |
|
Nelke C, Stascheit F, Eckert C, Pawlitzki M, Schroeter CB, Huntemann N, Mergenthaler P, Arat E, Öztürk M, Foell D, Schreiber S, Vielhaber S, Gassa A, Stetefeld H, Schroeter M, Berger B, Totzeck A, Hagenacker T, Meuth SG, Meisel A, Wiendl H, Ruck T. Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients. J Neuroinflammation. 2022, 19(1):89. doi: 10.1186/s12974-022-02448-4. |
|
Hußler W, Höhn L, Stolz C, Vielhaber S, Garz C, Schmitt FC, Gundelfinger ED, Schreiber S, Seidenbecher CI. Brevican and Neurocan Cleavage Products in the Cerebrospinal Fluid - Differential Occurrence in ALS, Epilepsy and Small Vessel Disease. Front Cell Neurosci. 2022,16:838432. doi: 10.3389/fncel.2022.838432. eCollection 2022. |
- Czauderna T, Haga J, Kim J, Klapperstück M, Klein K, Kuhlen T, Oeltze-Jafra S, Sommer B, Schreiber F. Immersive Analytics Applications in Life and Health Sciences. Chapter 10 in K. Marriott et al. (Eds): Immersive Analytics, Lecture Notes in Computer Science, vol 11190, pp. 289-330, 2018. Springer, Cham https://doi.org/10.1007/978-3-030-01388-2_10
Abstract:
Life and Health sciences are key application areas for immersive analytics. This spans a broad range including medicine (e.g., investigations in tumour boards), pharmacology (e.g., research of adverse drug reactions), biology (e.g., immersive virtual cells) and ecology (e.g., analytics of animal behaviour). We present a brief overview of general applications of immersive analytics in life and health sciences, and present a number of applications in detail, such as immersive analytics in structural biology, in medical image analytics, in neurosciences, in epidemiology, in biological network analysis an for virtual cells.